Research

Life Sciences & Biotechnology

Title :

Development of machine learning-based drug repurposing pipeline against SARS-CoV-2 and human proteome

Area of research :

COVID-19 Research, Life Sciences & Biotechnology

Focus area :

COVID-19 Therapeutics

Principal Investigator :

Dr Kamal Rawal, Associate Professor, Amity University, Uttar Pradesh

Timeline Start Year :

2020

Contact info :

Details

Executive Summary :

The study intends to develop artificial intelligence (AI) driven, integrative, antiviral drug repurposing platform.

Outcome/Output:

A web enabled resource for COVID-19 datasets, information and software has been created for the benefit of the scientific community. Further, a patient-centric cloud-based system to capture side effects and therapeutics of existing drugs used for COVID-19 treatment has been deployed.

Organizations involved

Implementing Agency :

Amity University, Uttar Pradesh

Funding Agency :

Department of Science and Technology (DST), Govt of India

Related Research

Colloidal quantum dots as enhancers in photocatalytic hydrogen generation
Supercomputer-based COVID-19 research: Priority allocation at the institute's High Performance Computing (HPC) facility
In-silico development of putative drugs for targeting SARS-CoV-2 Mpro
The U mask- a specially designed cloth-based and centre HEPA padding option
Evaluation of filter capacity of N-95 masks and PPE kit for the District Medical authotities